Related Experiment Video
Updated: Jul 11, 2025
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.0K
Pulmonary Cavitary Sarcoidosis: A Case Report.
1Department of Respiratory Medicine, Karuna Hospital, Kathmandu, NPL.
Cureus
|November 6, 2023
Summary
Pulmonary cavitary sarcoidosis, a rare manifestation of this granulomatous disease, can present with symptoms like cough and dyspnea. Early diagnosis and corticosteroid treatment are key for managing this uncommon condition.
Area of Science:
- Pulmonology
- Pathology
Background:
- Sarcoidosis is a multisystem granulomatous disease.
- Non-caseating granulomas are characteristic, but cavitary lesions are rare.
Observation:
- A 38-year-old male presented with cough, dyspnea, and weight loss.
- Chest CT revealed mediastinal/hilar lymphadenopathy, consolidation, and lung cavitation.
- Bronchoscopy confirmed non-necrotizing granulomas with hyaline sclerosis.
Findings:
- Diagnosis of pulmonary cavitary sarcoidosis was established.
- Treatment with systemic corticosteroids led to symptom improvement.
Implications:
- Highlights an uncommon presentation of sarcoidosis.
- Emphasizes the need for accurate diagnosis and management of cavitary sarcoidosis.
Related Concept Videos
01:28Pulmonary Tuberculosis II
243
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
243
01:27Pneumothorax-II
168
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
168
01:17Other Pulmonary Disorders
853
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
853
01:29Pulmonary Tuberculosis I
246
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
246